Literature DB >> 19703737

Recurrent acute cerebellar ataxia associated with anti-cardiolipin antibodies.

Nobutsune Ishikawa1, Masao Kobayashi.   

Abstract

Various autoantibodies are detected in patients with acute cerebellar ataxia (ACA). Although an autoimmune process may contribute to the mechanism of ACA, its pathophysiology is not completely understood. We report a girl with recurrent ACA and anti-cardiolipin antibodies. Her cerebral blood flow imaging showed hypoperfusion in the cerebellum, which improved when the anti-cardiolipin antibodies disappeared. Our case suggests that vasculopathy or non-vascular neurotoxicity in the cerebellum caused by antiphospholipid antibodies leads to acute cerebellar ataxia. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19703737     DOI: 10.1016/j.braindev.2009.07.009

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  5 in total

Review 1.  Non-stroke Central Neurologic Manifestations in Antiphospholipid Syndrome.

Authors:  Cécile M Yelnik; Elizabeth Kozora; Simone Appenzeller
Journal:  Curr Rheumatol Rep       Date:  2016-02       Impact factor: 4.592

Review 2.  Childhood cerebellar ataxia.

Authors:  Brent L Fogel
Journal:  J Child Neurol       Date:  2012-07-04       Impact factor: 1.987

Review 3.  Movement disorders in systemic lupus erythematosus and the antiphospholipid syndrome.

Authors:  José Fidel Baizabal-Carvallo; Cecilia Bonnet; Joseph Jankovic
Journal:  J Neural Transm (Vienna)       Date:  2013-04-13       Impact factor: 3.575

Review 4.  Neurologic Manifestations of the Antiphospholipid Syndrome - an Update.

Authors:  Miguel Leal Rato; Matilde Bandeira; Vasco C Romão; Diana Aguiar de Sousa
Journal:  Curr Neurol Neurosci Rep       Date:  2021-06-14       Impact factor: 5.081

5.  The association between serological biomarkers and primary Sjogren's syndrome associated with peripheral polyneuropathy.

Authors:  Che-Wei Hsu; Yu-Jih Su; Wen-Neng Chang; Nai-Wen Tsai; Wen-Chan Chiu; Ben-Chung Cheng; Chih-Min Su; Chi-Ren Huang; Ya-Ting Chang; Cheng-Hsien Lu
Journal:  Biomed Res Int       Date:  2014-04-13       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.